drugset / Trial / NCT02404363

Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy

NCT02404363

RandomizedParallel-groupTriple-blindTreatment

Summary

Clopidogrel has been shown to slow down tumor progression in orthoptic pancreatic murine tumor. In a pilot study, the rate of microparticles was correlated with response rate of pancreatic adenocarcinoma. The aim of the study is; * to compare the phenotypes of coagulation, the tumor progression and metastasis formation with and without clopidogrel treatment in association with chemotherapy in advanced pancreatic cancer patients * to correlate the decrease of microparticles levels after one month of chemotherapy with tumor response (ancillary study)

Timeline

Start
2016-01-11
Primary completion
2017-12-04
Completion
2018-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg